QUESTRA

This brand name is authorized in Nigeria.

Active ingredients

The drug QUESTRA contains one active pharmaceutical ingredient (API):

1	Colestyramine UNII 4B33BGI082 - CHOLESTYRAMINE
	Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels.
	Read more about Colestyramine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5905	Powder for suspension	Questra Powder For Oral Suspension PWD_F_SOL 4 g 5 x 10's (in sachets)	Powder for Oral Suspension in 5-g sachet Each sachet contains: Cholestyramine Resin USP 4 g	28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AC01	Colestyramine	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5905